How many acquisitions has SERB made so far?

SERB has completed 3 acquisitions so far, with an average acquisition amount of $412M.

In which year did SERB make the most acquisitions?

SERB was most active in 2023, with 2 acquisitions completed in that year.

List of 3 Acquisitions by SERB (Oct 2026)

Q: Which is SERB's latest acquisition?

SERB's most recent acquisition is Y-mAbs Therapeutics, a Provider of antibodies-based products targeting GD2 and B7H3 tumor antigens., acquired in August 2025.

SERB has made a total of 3 acquisitions. The organization recorded peak activity in 2023 with 2 transactions and in 2025 with 1 transaction. Operations have spanned 1 country, the United States, across 2 sectors: Oncology and Immunotherapy. From 2020 to 2025, the average number of acquisitions was 0.6 per year, with 0 acquisitions completed in the current calendar year. The most recent acquisition is Y-mAbs Therapeutics, a New York City-based provider of antibody-based products targeting GD2 and B7H3 tumor antigens, acquired in August 2025; the company was founded in 2014.

Recent acquisitions by SERB

SERB's most recent acquisition - Y-mAbs Therapeutics is a Provider of antibodies-based products targeting GD2 and B7H3 tumor antigens., founded in 2014 and located in New York City. SERB acquired it in August 2025 for a price of $*****.

Here is the list of all acquisitions by SERB sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Aug 05, 2025	Y-mAbs Therapeutics	qoum	kb{e	31	822
Jul 13, 2023	VISTOGARD®	ufag	iddq	70	511
Jul 13, 2023	Xuriden	buej	btlm	44	618

Media has covered SERB for a total of 4 events in the last 1 year, 2 of them have been about acquisition activity.

•

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa BiopharmaGlobeNewswire•Jul 01, 2026•Hansa Biopharma, SERB

•

Hansa Biopharma Enters Into €115 Million Licensing Agreement With SERB Pharmaceuticals For IDEFIRIX In Europe and MENAPR Newswire•May 19, 2026•Hansa Biopharma, Anusandhan National Research Foundation, SERB, Mayer Brown

View More SERB Recent News

View all Acquisitions by SERB

Acquisitions by SERB

List of SERB's Acquisitions

Recent acquisitions by SERB

News related to SERB's acquisitions

FAQs about Acquisitions by SERB